Drug Delivery Technology Market

The global top 10 drug delivery technology market size is estimated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the advancement in technology for instance, micro-needle transdermal patches, and novel intelligent inhalers.

Drug delivery is a procedure of operating a compound to gain a therapeutic impact in animals and humans, these systems are built technologies for the targeted delivery. Medicines are being accustomed for better health and extending lives. This technology improves the drug life cycle by enhancing drug efficacy and safety by extending patent rights.

Increasing demand for effective delivery of pharmaceutical and biopharmaceuticals with innovation in drug delivery technologies are key forces of the market expansion. Furthermore, introduction of self-administration and home-care drug delivery devices are expected to influence the market growth.

Drug delivery technology are revenue shooters as this technology improves drug life cycle and improve a competitive scope to the drug by rising drug safety. Moreover, rising applications of non-conventional drug delivery technology in transdermal, nasal, and pulmonary in diabetes and chronic conditions is expected to positively influence the market. 

Market Trends, Drivers, Restraints, and Opportunities

• Rising demand for advanced technology to improve drug delivery and ensure safety process are key factors driving the market growth.
• Increasing number of the aging population who are at high risks of exposing to various infectious and chronic illness present a major driver of the market.
• Rapid expansion of the biopharmaceutical operations and improving drugs developments are major factors to boost the market growth.
• Increasing applications of non-conventional drug delivery technology in chronic conditions is expected to fuel the market during the forecast period. 
• Drug failures, patient expirations, and other technical barriers of using drugs delivery are expected to hamper the market growth in the coming years.

Scope of the Drug Delivery Technology Market Report                         

The report on the global top 10 drug delivery technology market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Drug Delivery Technology Market Segment Insights

Sustained release segment is expected to grow at a robust pace

Based on applications, the global top 10 drug delivery technology market is divided into injectable, sustained release, aerosol, transdermal, implants, targeted delivery, pegylation, encapsulation, and liposomal. The sustained release segment is expected to grow at a robust pace during the projected period owing to the enormous popularity of daily formulations for the diseases.

However, the targeted delivery segment is projected to account for a key market share during the forecast period due to technology advancement and rising adoption level.

North America is anticipated to constitute a key market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America accounted for a key share of the market in 2019 and is expected to constitute a major market share during the targeted period due to technological innovations and massive investment on ongoing researches for drug delivery methods.

The market of Asia Pacific, however, is anticipated to expand at an impressive growth rate during the forecast period owing to the increasing patient awareness and rising disposable incomes of a large number of the population in the region.

Segments

The global top 10 drug delivery technology market has been segmented on the basis of

Applications

• Injectable
• Sustained Release
• Aerosol
• Transdermal
• Implants
• Targeted Delivery
• Pegylation
• Encapsulation
• Liposomal

Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Applied Pharma Ltd.
• Alkermes Inc.
• Nanopass Technologies Ltd.
• Altea Therapeutics Inc.
• Biovail Inc.
• Paradigm Inc.
• Ethypharm Ltd.
• Eurand Pharmaceuticals Inc.
• Elan Corp.
• Johnson & Johnson, Ltd.
• Nektar Therapeutics Ltd.
• Bioject Inc.
• Penwest Pharmaceuticals
• Vectura Group Plc.
• Durect Corp.
• Labopharm Europe Ltd.
• Skye Pharma Plc
• Endo Pharmaceuticals Inc.
• Flamel Technologies Inc.

Competitive Landscape

Key players competing in the global top 10 drug delivery technology market are Applied Pharma Ltd.; Alkermes Inc.; Nanopass Technologies Ltd.; Altea Therapeutics Inc.; Biovail Inc.; Paradigm Inc.; Ethypharm Ltd.; Eurand Pharmaceuticals Inc.; Elan Corp.; Johnson & Johnson, Ltd.; Nektar Therapeutics Ltd.; Bioject Inc.; Penwest Pharmaceuticals; Vectura Group Plc.; Durect Corp.; Labopharm Europe Ltd.; Skye Pharma Plc; Endo Pharmaceuticals Inc.; and Flamel Technologies Inc.

The main market players are continuously engaged in various development activities such as mergers and acquisitions, research and developments, investments for innovative products and collaborations to have their competitive edge in the market.